Որոնման արդյունքները - Antonella Argentiero
- Ցուցադրվում են 1 - 20 արդյունքները 23
- Գնացեք Հաջորդ էջ
-
1
The Complexity of the Tumor Microenvironment in Hepatocellular Carcinoma and Emerging Therapeutic Developments Antonella Argentiero, Antonella Delvecchio, Rossella Fasano, Alessandro Andriano, Ingrid Catalina Caradonna, Riccardo Memeo, Vanessa Desantis
Հրապարակվել է 2023Revisão -
2
-
3
Immune system and bone microenvironment: rationale for targeted cancer therapies Antonio Gnoni, Oronzo Brunetti, Vito Longo, Calabrese Angela, Antonella Argentiero, Roberto Calbi, Antonio Giovanni Solimando, Antonella Licchetta
Հրապարակվել է 2020Revisão -
4
Emerging Role of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma Vito Longo, Oronzo Brunetti, Antonio Gnoni, Antonella Licchetta, Sabina Delcuratolo, Riccardo Memeo, Antonio Giovanni Solimando, Antonella Argentiero
Հրապարակվել է 2019Revisão -
5
Role of BRAF in Hepatocellular Carcinoma: A Rationale for Future Targeted Cancer Therapies Antonio Gnoni, Antonella Licchetta, Riccardo Memeo, Antonella Argentiero, Antonio Giovanni Solimando, Vito Longo, Sabina Delcuratolo, Oronzo Brunetti
Հրապարակվել է 2019Revisão -
6
-
7
Immune‑related adverse events during anticancer immunotherapy: Pathogenesis and management (Review) Luigia Stefania Stucci, Raffaele Palmirotta, Anna Passarelli, Erica Silvestris, Antonella Argentiero, Laura Lanotte, Silvana Acquafredda, Annalisa Trama, Franco Silvestris
Հրապարակվել է 2017Artigo -
8
Skeletal Metastases of Unknown Primary: Biological Landscape and Clinical Overview Antonella Argentiero, Antonio Giovanni Solimando, Oronzo Brunetti, Angela Calabrese, Francesco Pantano, Michele Iuliani, Daniele Santini, Nicola Silvestris, Angelo Vacca
Հրապարակվել է 2019Revisão -
9
Anti-angiogenesis and Immunotherapy: Novel Paradigms to Envision Tailored Approaches in Renal Cell-Carcinoma Antonella Argentiero, Antonio Giovanni Solimando, Markus Krebs, Patrizia Leone, Nicola Susca, Oronzo Brunetti, Vito Racanelli, Angelo Vacca, Nicola Silvestris
Հրապարակվել է 2020Revisão -
10
Current Approaches for Combination Therapy of Cancer: The Role of Immunogenic Cell Death Zahra Asadzadeh, Elham Safarzadeh, Sahar Safaei, Ali Baradaran, Ali Mohammadi, Khalil Hajiasgharzadeh, Afshin Derakhshani, Antonella Argentiero, Nicola Silvestris, Behzad Baradaran
Հրապարակվել է 2020Revisão -
11
The Role of V-Domain Ig Suppressor of T Cell Activation (VISTA) in Cancer Therapy: Lessons Learned and the Road Ahead Negar Hosseinkhani, Afshin Derakhshani, Mahdi Abdoli Shadbad, Antonella Argentiero, Vito Racanelli, Tohid Kazemi, Ahad Mokhtarzadeh, Oronzo Brunetti, Nicola Silvestris, Behzad Baradaran
Հրապարակվել է 2021Revisão -
12
Predictive and Prognostic Factors in HCC Patients Treated with Sorafenib Oronzo Brunetti, Antonio Gnoni, Antonella Licchetta, Vito Longo, Angela Calabrese, Antonella Argentiero, Sabina Delcuratolo, Antonio Giovanni Solimando, Andrea Casadei‐Gardini, Nicola Silvestris
Հրապարակվել է 2019Revisão -
13
The Evolving Role of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma Treatment Patrizia Leone, Antonio Giovanni Solimando, Rossella Fasano, Antonella Argentiero, Eleonora Malerba, Alessio Buonavoglia, L. Lupo, Vallì De Re, Nicola Silvestris, Vito Racanelli
Հրապարակվել է 2021Revisão -
14
Actors on the Scene: Immune Cells in the Myeloma Niche Patrizia Leone, Antonio Giovanni Solimando, Eleonora Malerba, Rossella Fasano, Alessio Buonavoglia, Fabrizio Pappagallo, Vallì De Re, Antonella Argentiero, Nicola Silvestris, Angelo Vacca, Vito Racanelli
Հրապարակվել է 2020Revisão -
15
Immune Checkpoint Inhibitors in Colorectal Cancer: Challenges and Future Prospects Shima Makaremi, Zahra Asadzadeh, Nima Hemmat, Amir Baghbanzadeh, Alessandro Sgambato, Farid Ghorbaninezhad, Hossein Safarpour, Antonella Argentiero, Oronzo Brunetti, Renato Bernardini, Nicola Silvestris, Behzad Baradaran
Հրապարակվել է 2021Revisão -
16
Gene Expression Comparison between the Lymph Node-Positive and -Negative Reveals a Peculiar Immune Microenvironment Signature and a Theranostic Role for WNT Targeting in Pancreatic... Antonella Argentiero, Simona De Summa, R. Fonte, Rosa Maria Iacobazzi, Letizia Porcelli, Matteo C. Da Vià, Oronzo Brunetti, Amalia Azzariti, Nicola Silvestris, Antonio Giovanni Solimando
Հրապարակվել է 2019Artigo -
17
Gene Expression Comparison Between the Lymph Node-Positive and Negative Reveals a Peculiar Immune-microenvironment Signature and a Theranostic Role for WNT Targeting in Pancreatic... Antonella Argentiero, Simona De Summa, R. Fonte, Rosa Maria Iacobazzi, Letizia Porcelli, Matteo C. Da Vià, Oronzo Brunetti, Amalia Azzariti, Nicola Silvestris, Antonio Giovanni Solimando
Հրապարակվել է 2019Pré-impressão -
18
A Systematic Review on the Therapeutic Potentiality of PD-L1-Inhibiting MicroRNAs for Triple-Negative Breast Cancer: Toward Single-Cell Sequencing-Guided Biomimetic Delivery Mahdi Abdoli Shadbad, Sahar Safaei, Oronzo Brunetti, Afshin Derakhshani, Parisa Lotfinejad, Ahad Mokhtarzadeh, Nima Hemmat, Vito Racanelli, Antonio Giovanni Solimando, Antonella Argentiero, Nicola Silvestris, Behzad Baradaran
Հրապարակվել է 2021Revisão -
19
Second-line treatments for Advanced Hepatocellular Carcinoma: A Systematic Review and Bayesian Network Meta-analysis Antonio Giovanni Solimando, Nicola Susca, Antonella Argentiero, Oronzo Brunetti, Patrizia Leone, Vallì De Re, Rossella Fasano, Markus Krebs, Elisabetta Petracci, Irene Azzali, Oriana Nanni, Nicola Silvestris, Angelo Vacca, Vito Racanelli
Հրապարակվել է 2021Revisão -
20
Liquid biopsy and tumor heterogeneity in metastatic solid tumors: the potentiality of blood samples Marco Russano, Andrea Napolitano, Giulia Ribelli, Michele Iuliani, Sonia Simonetti, Fabrizio Citarella, Francesco Pantano, Emanuela Dell’Aquila, Cecilia Anesi, Nicola Silvestris, Antonella Argentiero, Antonio Giovanni Solimando, Bruno Vincenzi, Giuseppe Tonini, Daniele Santini
Հրապարակվել է 2020Revisão
Որոնման գործիքներ:
Առնչվող խորագիր
Medicine
Internal medicine
Cancer
Biology
Cancer research
Immunology
Immune system
Immunotherapy
Tumor microenvironment
Biochemistry
Immune checkpoint
Bioinformatics
Hepatocellular carcinoma
Oncology
Gene
T cell
Cancer immunotherapy
Genetics
Angiogenesis
Clinical trial
Intensive care medicine
Metastasis
Pathology
Sorafenib
Adverse effect
Antibody
Antigen
Bone marrow
CTLA-4
Cabozantinib